In previous studies, we have shown that immunisation with Mage-b combined with GM-CSF plasmid DNA and thioglycollate reduced the number of metastases by 65% compared with the control group in a highly metastatic breast tumour model, 4T1 (Gravekamp et al, 2008). Here, CSF2 is linked to breast neoplasm.